GlassScriptPhysician profile
Justin Alan Armstrong
NPI 1114583523
$3,476.03
in general payments reported to CMS, 2019-2025
15 companies · $1,469 in 2025
The $1,469 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $979 · 2024: $1,028 · 2025: $1,469.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,069 · Travel and Lodging: $1,318 · Education: $89.25.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,068.85 |
| Travel and Lodging | $1,317.93 |
| Education | $89.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $1,617.23 | 2023-2025 | Impella |
| Boston Scientific Corporation | $506.86 | 2025 | Avvigo Guidance System, General - Vascular Access, Synergy |
| Shockwave Medical, INC | $227.45 | 2024-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abbott Laboratories | $219.32 | 2025 | Optis, Perclose Prostyle |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $198.84 | 2023-2025 | Lifevest |
| Astrazeneca Pharmaceuticals LP | $131.90 | 2024 | |
| Janssen Pharmaceuticals, INC | $124.99 | 2024 | Xarelto |
| Amgen INC. | $124.24 | 2023 | Repatha |
| E.R. Squibb & Sons, L.L.C. | $120.93 | 2023 | Camzyos |
| Becton, Dickinson and Company | $67.09 | 2025 | Hemosphere |
| Stryker Corporation | $54.74 | 2025 | Artix Mt |
| Spectrawave, INC | $31.08 | 2025 | Starlight Imaging Catheter, Hypervue Imaging System |
| Medtronic, INC. | $21.17 | 2024 | Azure Xt Dr Mri Surescan |
| Novartis Pharmaceuticals Corporation | $15.37 | 2025 | |
| Cordis US Corp. | $14.82 | 2025 | Mynx Control |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Justin Armstrong listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.